| Jessica Spurrier, | |
|
3406 Glacier Hwy, Juneau, AK 99801-7251 | |
| (907) 463-3303 | |
| (907) 463-6858 |
| Full Name | Jessica Spurrier |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3406 Glacier Hwy, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104466101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Spurrier, 3406 Glacier Hwy, Juneau, AK 99801-7251 Ph: (907) 463-3303 | Jessica Spurrier, 3406 Glacier Hwy, Juneau, AK 99801-7251 Ph: (907) 463-3303 |
News Archive
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
Researchers studying yeast cells have identified a metabolic enzyme as a potential therapeutic target for treating Huntington's disease, a fatal inherited neurodegenerative disorder for which there is currently no effective treatment. The group, whose results appear in the May issue of Nature Genetics, includes researchers from the University of Washington School of Medicine in Seattle and the University of Maryland School of Medicine in Baltimore.
Scientists at Mayo Clinic, Jacksonville, Florida created a novel mouse that exhibits the symptoms and neurodegeneration associated with the most common genetic forms of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), both of which are caused by a mutation in the a gene called C9ORF72.
› Verified 3 days ago
Becky A Iverson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Ms. Jessica E Jones, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 320 W Willoughby Ave, Juneau, AK 99801 Phone: 907-463-7305 | |
Mr. Edward James Williams, MSW,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3245 Hospital Drive, Juneau, AK 99801 Phone: 907-364-4499 Fax: 907-364-1539 | |
Norman L Haskell, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-586-3877 | |
Kiley Heth, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Michaela Demmert, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 320 W Willoughby Ave, Juneau, AK 99801 Phone: 907-463-7305 |